Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24914549 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Citalopram for Agitation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Agitation
Interventions: Drug: citalopram;   Drug: placebo

Indicates status has not been verified in more than two years